MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival.
Fiche publication
Date publication
mars 2024
Journal
BMC cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr ALPY Fabien, Pr CHENARD Marie-Pierre, Pr MATHELIN Carole, Dr TOMASETTO Catherine
Tous les auteurs :
Molière S, Lodi M, Leblanc S, Gressel A, Mathelin C, Alpy F, Chenard MP, Tomasetto C
Lien Pubmed
Résumé
Early hormone-positive breast cancers typically have favorable outcomes, yet long-term surveillance is crucial due to the risk of late recurrences. While many studies associate MMP-11 expression with poor prognosis in breast cancer, few focus on early-stage cases. This study explores MMP-11 as an early prognostic marker in hormone-positive breast cancers.
Mots clés
Breast MRI, Breast cancer, Immunohistochemistry, MMP-11, Microenvironment, Recurrence
Référence
BMC Cancer. 2024 03 4;24(1):295